Journal News
-
Monday, August 30, 2010
|
Source: Circulation
-
By Jason Kahn
African Americans are at increased risk of definite drug eluting stent (DES) thrombosis, independent of other factors such as socioeconomic status…
-
Friday, August 27, 2010
|
Source: Circulation
-
By L.A. McKeown
Although major bleeding is a legitimate reason for discontinuing dual antiplatelet therapy, a study that examined reasons for discontinuation found…
-
Friday, August 27, 2010
|
Source: Circulation: Cardiovascular Interventions
-
By Caitlin E. Cox
Inducing rapid hypothermia in patients with ST segment elevation myocardial infarction (STEMI) prior to primary percutaneous coronary intervention…
-
Thursday, August 26, 2010
|
Source: Circulation
-
By Jason Kahn
Stable patients with multivessel disease fare better in terms of long term outcomes with coronary artery bypass grafting (CABG) compared with medical…
-
Wednesday, August 25, 2010
|
Source: Journal of the American College of Cardiology
-
By Kim Dalton
Transcatheter aortic valve implantation (TAVI) via the transapical route can result in low early mortality even in very high risk patients once operators…
-
Wednesday, August 25, 2010
|
Source: Journal of the American College of Cardiology
-
By Caitlin E. Cox
New P2Y12 inhibitors offer a mortality benefit over clopidogrel after percutaneous coronary intervention (PCI), according to a meta analysis published…
-
Tuesday, August 24, 2010
|
Source: Journal of the American Medical Association
-
By L.A. McKeown
Elective use of intra aortic balloon pump (IABP) therapy during percutaneous coronary intervention (PCI) does not reduce the incidence of major adverse…
-
Monday, August 23, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Kim Dalton
Physiological assessment of intermediate lesions with fractional flow reserve (FFR) reduces percutaneous coronary interventions by two thirds compared…
-
Monday, August 23, 2010
|
Source: American Journal of Cardiology
-
By Jason Kahn
One year results show that bivalirudin monotherapy yields equivalent rates of adverse cardiac events compared with heparin plus a glycoprotein IIb…
-
Friday, August 20, 2010
|
Source: Circulation: Cardiovascular Quality and Outcomes
-
By L.A. McKeown
An analysis of patients who have non ST segment elevation acute coronary syndromes (NSTE ACS) and the physicians who treat them suggests that optimal…
-
Friday, August 20, 2010
|
Source: European Heart Journal
-
By Alison Palkhivala
In patients with acute coronary syndromes without ST segment elevation (NSTE ACS), an early invasive strategy can reduce the risk of recurrent ischemia…
-
Thursday, August 19, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Jason Kahn
Over one quarter of patients with isolated anterior ST segment depression on electrocardiogram (ECG) may require urgent cardiac catheterization, even…
-
Wednesday, August 18, 2010
|
Source: American Journal of Cardiology
-
By Kim Dalton
Transitioning from femoral to radial access for cardiac catheterization is associated with longer fluoroscopy time as well as a small increase in radiation…
-
Wednesday, August 18, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Heather Lindsey
Retroperitoneal hematoma after percutaneous coronary intervention (PCI) is uncommon but can have serious consequences, including increased risk of…
-
Tuesday, August 17, 2010
|
Source: Journal of the American Medical Association
-
By L.A. McKeown
Although door to balloon (D2B) times have been the focus of much research and policy initiatives with regard to patients with ST segment elevation…
-
Tuesday, August 17, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Alison Palkhivala
Treating patients undergoing primary percutaneous coronary intervention (PCI) with bivalirudin rather than heparin and a glycoprotein IIb IIIa inhibitor…
-
Monday, August 16, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Kim Dalton
Given the available repertoire of prosthetic valves and approaches, the vast majority of candidates for transcatheter aortic valve implantation (TAVI)…
-
Monday, August 16, 2010
|
Source: JACC: Cardiovascular Interventions
-
By Jason Kahn
A protocol utilizing careful selection criteria and thorough pre discharge evaluation allows up to 1 in 7 patients undergoing uncomplicated elective…
-
Friday, August 13, 2010
|
Source: Catheterization and Cardiovascular Interventions
-
By Caitlin E. Cox
Embolic protection devices have been shown to lower acute myocardial infarction (MI) risk by approximately 40% after stenting saphenous vein graft…
-
Friday, August 13, 2010
|
Source: Journal of Vascular Surgery
-
By L.A. McKeown
For patients who develop significant stenosis after carotid endarterectomy (CEA), carotid artery stenting (CAS) is as safe as repeat CEA, researchers…
-
Thursday, August 12, 2010
|
Source: Circulation, Cardiovascular Interventions
-
By Jason Kahn
Myocardial blush grade as assessed by the operator during primary percutaneous coronary intervention (PCI) correlates strongly with 1 year mortality,…
-
Wednesday, August 11, 2010
|
Source: Journal of the American College of Cardiology
-
By Kim Dalton
Patients who carry a loss of function allele and show high platelet reactivity after an initial clopidogrel loading dose can usually achieve a protective…
-
Wednesday, August 11, 2010
|
Source: Journal of Vascular Surgery
-
By Caitlin E. Cox
Patients with aorto iliac occlusive disease who receive endovascular treatment have fewer short term complications and improved economic outcomes compared…
-
Tuesday, August 10, 2010
|
Source: Archives of Internal Medicine
-
By L.A. McKeown
Retrievable vena cava filters used to treat venous thromboembolism appear to have a high rate of fracture and systemic migration, according to a small…
-
Monday, August 9, 2010
|
Source: Stroke
-
By Jason Kahn
Women with severe carotid stenosis who suffer a transient ischemic attack (TIA) are less likely than men to receive carotid endarterectomy (CEA). Moreover,…
-
Monday, August 9, 2010
|
Source: American Journal of Cardiology
-
By Kim Dalton
Many very elderly patients who present with ST segment elevation myocardial infarction (STEMI) are candidates for primary percutaneous coronary intervention…
-
Friday, August 6, 2010
|
Source: Circulation: Cardiovascular Quality and Outcomes
-
By Caitlin E. Cox
More than 40% of Medicare patients with acute myocardial infarction (AMI) who are initially admitted to hospitals without revascularization capability…
-
Friday, August 6, 2010
|
Source: American Journal of Cardiology
-
By L.A. McKeown
Clinically driven target lesion revascularization (TLR) appears to be associated with an increased risk of cardiac death or myocardial infarction (MI)…
-
Thursday, August 5, 2010
|
Source: Journal of Vascular Surgery
-
By Jason Kahn
Due to biological factors such as unstable plaque, patients with symptomatic carotid artery disease are largely inappropriate candidates for stenting,…
-
Wednesday, August 4, 2010
|
Source: Annals of Internal Medicine
-
By Kim Dalton
In the 8 years since the first successful transcatheter aortic valve implantation (TAVI), the technology has emerged as a feasible alternative to surgery…
Conference News
-
Friday, September 3, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—Improvements in care for acute myocardial infarction (AMI) over a 12 year period in Sweden have led to dramatically better outcomes,…
-
Friday, September 3, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—A small feasibility study shows “encouraging” 3 year findings with regard to percutaneous treatment of functional mitral regurgitation…
-
Thursday, September 2, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—The use of unfractionated heparin (UFH) in percutaneous coronary intervention (PCI) is fraught with issues such as bleeding risk…
-
Thursday, September 2, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—Everolimus eluting stents (EES) appear to provide improved long term outcomes compared with sirolimus eluting stents (SES), in part…
-
Thursday, September 2, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—Long term registry data demonstrate that the GRACE risk score predicts adverse outcomes through 5 years in patients with acute coronary…
-
Wednesday, September 1, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—Patients who experience bleeding while on prolonged dual antiplatelet therapy are more likely to suffer adverse events and or discontinue…
-
Wednesday, September 1, 2010
|
Source: European Heart Journal
-
By Caitlin E. Cox
STOCKHOLM, Sweden—The European Society of Cardiology (ESC) has released new clinical practice guidelines offering a comprehensive look at coronary…
-
Wednesday, September 1, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—Acute coronary syndrome (ACS) patients treated with the factor Xa inhibitor fondaparinux can safely undergo percutaneous coronary…
-
Tuesday, August 31, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—Two studies presented August 29, 2010, at the European Society of Cardiology (ESC) Congress demonstrated the effectiveness of the…
-
Tuesday, August 31, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—At 2 years, the putative late safety advantage of a biodegradable polymer drug eluting stent (DES) over permanent polymer DES has…
-
Tuesday, August 31, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—Results of 2 trials exploring the interaction between genetics and antiplatelet therapies have, from different perspectives, cast…
-
Monday, August 30, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—Intracoronary bone marrow stem cell (BMC) therapy for chronic heart failure patients appears to provide multiple benefits, ranging…
-
Monday, August 30, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—A pair of phase 2 studies testing experimental antiplatelet agents—1 in patients undergoing nonurgent percutaneous coronary intervention…
-
Monday, August 30, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden—Despite analysis of comprehensive data on more than 1,000 patients undergoing transcatheter aortic valve implantation (TAVI) from…
-
Sunday, August 29, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Kim Dalton
STOCKHOLM, Sweden — A high dose of erythropoietin (EPO) delivered soon after successful primary percutaneous coronary intervention (PCI) in patients…
-
Sunday, August 29, 2010
|
Source: European Society of Cardiology Congress 2010
-
By Caitlin E. Cox
STOCKHOLM, Sweden—In patients with ST segment elevation myocardial infarction (STEMI), sirolimus eluting stents (SES) show sustained efficacy at reducing…
-
Tuesday, June 1, 2010
|
Source: EuroPCR 2010
-
By Kim Dalton
PARIS, France—The late breaking trials featured at last week’s EuroPCR 2010 were the winners from among a record 70 plus submissions. Several offered…
-
Friday, May 28, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—In patients who are not given or do not respond to clopidogrel before elective percutaneous coronary intervention (PCI), intracoronary…
-
Friday, May 28, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—In patients undergoing percutaneous coronary intervention (PCI) who experience stent thrombosis, stent fracture and strut malapposition…
-
Friday, May 28, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—In patients who are carriers of the CYP2C19 2 loss of function allele, progressively increasing the clopidogrel loading dose may help…
-
Friday, May 28, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—Transcatheter aortic valve implantation (TAVI) is associated with a high rate of new silent cerebral ischemic lesions, regardless of…
-
Thursday, May 27, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—Late breaking trials presented May 25 at EuroPCR 2010 provided good news about real world use of 2 different biolimus A9 eluting stents…
-
Thursday, May 27, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—When performing cardiac catheterization via the transradial approach, accessing through the left radial artery slightly lowers fluoroscopy…
-
Thursday, May 27, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—Two new stents, one with a “passive” coating to reduce inflammation, the other a drug eluting stent (DES) that releases a sirolimus analog,…
-
Thursday, May 27, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—The first full year of experience with a transcatheter aortic valve implantation (TAVI) in over 1,000 patients, many of them not eligible…
-
Wednesday, May 26, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—In the latest setback for an intriguing technology, a paclitaxel eluting balloon combined with a bare metal stent (BMS) failed to improve…
-
Wednesday, May 26, 2010
|
Source: EuroPCR
-
By Caitlin E. Cox
PARIS, France—Twelve month results for a new sirolimus eluting stent featuring micro reservoirs and a biodegradable polymer show promising clinical…
-
Wednesday, May 26, 2010
|
Source: EuroPCR 2010
-
By Jason Kahn
PARIS, France—Everolimus eluting stents are angiographically superior to paclitaxel eluting stents in diabetic subjects. Moreover, they are associated…
-
Wednesday, May 26, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—Mechanical thrombectomy added to direct stenting in patients experiencing ST segment elevation myocardial infarction (STEMI) improves…
-
Tuesday, May 25, 2010
|
Source: EuroPCR 2010
-
By Caitlin E. Cox
PARIS, France—A novel zotarolimus eluting stent (ZES) shows equivalent safety and effectiveness compared with an everolimus eluting stent (EES) already…
|